Our vision is to become the centre of excellence for ion channel diseases also known as “channelopathies”. We provide next generation ion channel tools to support and accelerate our client’s research projects in drug discovery and diagnosis, with the aim of facilitating the design of new treatments.

The close links between prevention, diagnosis and treatment are a basic prerequisite for the development of new and highly individualized cures to improve patient’s quality of life. Genionics actively promotes the paradigm shift from single gene screening to ion channel allele screening. These advances represent a contribution to the overall progress in personalized medicine.

Behind our ion channel cell products stands extensive scientific know-how. Genionics’ mission is the efficient conversion of our proprietary technology into high-end ion channel tools to establish a comprehensive collection of cell line reagents. Our current products are offered in the ChanCloneTM catalogue.